ArticleRMD open2023

Disease-modifying anti-rheumatic drugs associated with different diabetes risks in patients with rheumatoid arthritis.

Yu-Jih Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.